ISRCTN31343854已完成未知
Randomised controlled trial of fibrinolytic aided pleural drainage during chemical pleurodesis for malignant pleural effusion
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •40 patients:
- •1. Confirmed pleural malignancy
- •2. Recurrent symptomatic pleural effusion
- •3. Aged 18-85
- •40 control patients, same criteria.
排除标准
- •Previous pleurodesis
研究者
相似试验
已完成
不适用
Clinical randomization of an Antifibrinolytic agent in Significant HaemorrhageHaemorrhage following traumaSLCTR/2007/008ondon School of Hygiene and Tropical Medicine
已完成
不适用
Randomized clinical trial for Fibrin Sealant in knee surgerytotal knee replacementknee surgery10005944NL-OMON31572Sanquin Bloedbank257
进行中(未招募)
1 期
se of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusio- Major patient- Patient with malignant hemopathy requiring intensive chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation- Grade = 1 hemorrhagic symptom according to WHO - WHO classification- Body weight between 38 and 78 kg- Patient presenting with a platelet refractory state defined according to the Corrected Count Increment (CCI)- Patient affiliated to a social security schemeMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864EUCTR2021-000990-10-FRInstitut de Cancérologie Lucien Neuwirth10
进行中(未招募)
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865EUCTR2011-002685-20-PLCSL Behring GmbH152
进行中(未招募)
不适用
REPLACE (Randomized evaluation of fibrinogen versus placeboin complex cardiovascular surgery): a prospective, multinational,multicenter, randomized, double-blind, placebo-controlled, phaseIII study for the use of Fibrinogen Concentrate (Human) (FCH) incomplex cardiovascular surgeryAcute bleeding while undergoing aortic replacement surgeryMedDRA version: 14.1Level: LLTClassification code 10049052Term: Aortic surgery NOSSystem Organ Class: 100000004865EUCTR2011-002685-20-FICSL Behring GmbH152
